Remdesivir , is approved in India for the treatment of suspected or laboratory confirmed incidences of COVID-19 in adults and children hospitalized with severe presentations of the disease....
As the incidence of COVID-19 cases continue to rise, we will need multiple approaches to effectively deal with this pandemic. Clinicians are evaluating Favipiravir for use in mild-to-moderat...
Welcome to an exciting international exchange of experiences on "Remdesivir for the Treatment of Severe COVID-19"; the live webinar was held on 28th August 2020. In India,...
The challenges of conducting trials against the backdrop of the COVID-19 pandemic will continue as we collectively journey into the “new normal”. Welcome to the recorded webinar on &...
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that was declared a global pandemic in March 2020 by the WHO. During...
